However, in contrast to the persistent induction of apoptosis, proliferation was no longer deeply suppressed at 24 h post-dosing in response to RAS inhibition in EP tumours (Fig. 5l, cyclin A2; see ‘Mechanisms of resistance to RMC-7977’). Here, CCNA2 is linked to neoplasm.